JP2005506173A - 組織調製のための超臨界流体抽出プロセス - Google Patents

組織調製のための超臨界流体抽出プロセス Download PDF

Info

Publication number
JP2005506173A
JP2005506173A JP2003535837A JP2003535837A JP2005506173A JP 2005506173 A JP2005506173 A JP 2005506173A JP 2003535837 A JP2003535837 A JP 2003535837A JP 2003535837 A JP2003535837 A JP 2003535837A JP 2005506173 A JP2005506173 A JP 2005506173A
Authority
JP
Japan
Prior art keywords
tissue
carbon dioxide
supercritical
supercritical fluid
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506173A5 (https=
Inventor
ラルフ カフェスジャン，
マイロン ジェイ． ホワネック，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Publication of JP2005506173A publication Critical patent/JP2005506173A/ja
Publication of JP2005506173A5 publication Critical patent/JP2005506173A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Extraction Or Liquid Replacement (AREA)
JP2003535837A 2001-10-17 2002-10-04 組織調製のための超臨界流体抽出プロセス Pending JP2005506173A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/981,274 US7008591B2 (en) 2001-10-17 2001-10-17 Supercritical fluid extraction process for tissue preparation
PCT/US2002/032027 WO2003033035A1 (en) 2001-10-17 2002-10-04 Supercritical fluid extraction process for tissue preparation

Publications (2)

Publication Number Publication Date
JP2005506173A true JP2005506173A (ja) 2005-03-03
JP2005506173A5 JP2005506173A5 (https=) 2006-05-25

Family

ID=25528256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003535837A Pending JP2005506173A (ja) 2001-10-17 2002-10-04 組織調製のための超臨界流体抽出プロセス

Country Status (5)

Country Link
US (1) US7008591B2 (https=)
EP (1) EP1436016A1 (https=)
JP (1) JP2005506173A (https=)
CA (1) CA2462717C (https=)
WO (1) WO2003033035A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018526056A (ja) * 2016-01-08 2018-09-13 アクロ バイオメディカル カンパニー． エルティーディー．Ａｃｒｏ Ｂｉｏｍｅｄｉｃａｌ Ｃｏｍｐａｎｙ． Ｌｔｄ． 無細胞角膜、その製造方法、及びその使用

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001059A2 (en) * 2003-06-23 2005-01-06 Novasterilis Inc. Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US8034288B2 (en) * 2003-06-23 2011-10-11 Novasterilis Method and apparatus for cleaning of viable donor soft tissue
WO2005000364A2 (en) * 2003-06-23 2005-01-06 Novasterilis Inc. Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
US8974730B2 (en) 2003-06-23 2015-03-10 Novasterilis, Inc. Process for creating acellular viable donor soft tissue
NZ544311A (en) * 2003-06-30 2008-12-24 Groningen Acad Ziekenhuis Method for histoprocessing
WO2005065396A2 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
TWI302944B (en) * 2004-07-12 2008-11-11 Method for removing virus activity from biological materials
US7422607B2 (en) * 2004-08-24 2008-09-09 Oviatt Henry W Anti-calcification treatments for heart valves and vascular grafts
FR2891052B1 (fr) * 2005-09-21 2007-12-21 Histolex Soc Responsabilite Li Procede de preparation d'un echantillon
CN101365499A (zh) * 2005-11-01 2009-02-11 骨骼技术股份有限公司 骨基质组合物和方法
US7666369B2 (en) * 2006-09-29 2010-02-23 Tyco Healthcare Group Lp System and method for recycling sterilant gas
US8268238B2 (en) * 2006-09-29 2012-09-18 Tyco Healthcare Group Lp System and method for recycling sterilant gas
US9173967B1 (en) 2007-05-11 2015-11-03 SDCmaterials, Inc. System for and method of processing soft tissue and skin with fluids using temperature and pressure changes
US20100323440A1 (en) * 2007-06-12 2010-12-23 Musculoskeletal Transplant Foundation Process for sterilizing acellular soft tissue under pressure
CA2690457C (en) 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
WO2008157492A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
CA3062443C (en) * 2007-06-15 2022-03-15 Warsaw Orthopedic, Inc. Method of treating tissue
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
WO2009009684A1 (en) * 2007-07-10 2009-01-15 Osteotech, Inc. Delivery system
US8507401B1 (en) 2007-10-15 2013-08-13 SDCmaterials, Inc. Method and system for forming plug and play metal catalysts
US8202539B2 (en) * 2007-10-19 2012-06-19 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
WO2010093959A2 (en) 2009-02-12 2010-08-19 Osteotech, Inc. Delivery systems, tools, and methods of use
CA2770490C (en) * 2009-08-11 2024-04-16 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
EP2475405B1 (en) 2009-09-09 2016-04-13 Cook Medical Technologies LLC Substrate surface modification utilizing a densified fluid and a surface modifier
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
US20130079494A1 (en) * 2011-09-22 2013-03-28 Tyco Healthcare Group Lp Processing Tissue Utilizing Supercritical Fluid
US8563234B2 (en) * 2012-02-23 2013-10-22 Anastasios J. Tousimis Critical point drying systems and methods for in situ tissue preservation
US8956566B2 (en) 2012-03-12 2015-02-17 Pure Biosolutions, Llc System and method for virus inactivation
CN102755665A (zh) * 2012-07-31 2012-10-31 中国辐射防护研究院 一种异种骨移植材料的制备方法
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US20150258245A1 (en) * 2014-03-13 2015-09-17 Warsaw Orthopedic. Inc. Method of delipidation and/or terminal sterilization for bone material
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11185610B2 (en) * 2015-08-11 2021-11-30 Acro Biomedical Company. Ltd. Preparation of acellular cartilage graft and uses thereof
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US20180353630A1 (en) * 2015-12-24 2018-12-13 Crititech, Inc. System and Methods for Tissue Sterilization
WO2018031265A1 (en) * 2016-08-08 2018-02-15 Allosource Supercritical carbon dioxide tissue processing methods
KR101954905B1 (ko) * 2016-08-08 2019-03-08 주식회사 도프 지방흡입 유출물로부터 초임계공정을 이용하여 콜라겐을 분리하는 방법
WO2018030748A1 (ko) * 2016-08-08 2018-02-15 주식회사 도프 지방흡입 유출물로부터 초임계공정을 이용하여 콜라겐을 분리하는 방법
US10428306B2 (en) 2016-08-12 2019-10-01 Warsaw Orthopedic, Inc. Method and system for tissue treatment with critical/supercritical carbon dioxide
FR3137839B1 (fr) * 2022-07-18 2026-04-24 Biobank Procédé et installation de traitement d’un tissu d'origine humaine ou animale, utilisant une circulation dynamique de fluide supercritique additivé
US20240173443A1 (en) 2022-11-25 2024-05-30 InnovMedics, LLC Sterilizing biological tissue with supercritical carbon dioxide

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900644A (en) 1955-11-01 1959-08-25 Johnson & Johnson Heterograft material
US3974526A (en) 1973-07-06 1976-08-17 Dardik Irving I Vascular prostheses and process for producing the same
US3927422A (en) 1973-12-12 1975-12-23 Philip Nicholas Sawyer Prosthesis and method for making same
US3966401A (en) 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
US4239492A (en) 1979-06-14 1980-12-16 Beisang Arthur A Method of preparing vascular grafts of human and other umbilical cord origins for tissue ingrowth
US4547292A (en) 1983-10-31 1985-10-15 General Electric Company Supercritical fluid extraction and enhancement for liquid liquid extraction processes
US4770780A (en) 1984-04-25 1988-09-13 Cf Systems Corporation Liquid CO2 /cosolvent extraction
US4877530A (en) 1984-04-25 1989-10-31 Cf Systems Corporation Liquid CO2 /cosolvent extraction
US4553974A (en) 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4755593A (en) 1985-07-24 1988-07-05 Lauren Mark D Novel biomaterial of cross-linked peritoneal tissue
FR2586938B1 (fr) 1985-09-06 1989-10-20 Commissariat Energie Atomique Procede et dispositif pour l'extraction de constituants par un fluide supercritique
US4749522A (en) 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4880543A (en) 1987-08-31 1989-11-14 Aluminum Company Of America Supercritical fluid chromatography packing material containing alumina
US4816159A (en) 1987-08-31 1989-03-28 Aluminum Company Of America Supercritical fluid chromatography packing material
US5084239A (en) 1990-08-31 1992-01-28 Abtox, Inc. Plasma sterilizing process with pulsed antimicrobial agent treatment
JP4260877B2 (ja) 1992-03-02 2009-04-30 バイオエング・インコーポレーテッド ウイルスの不活性化方法
FR2695140B1 (fr) 1992-08-06 1994-11-04 Aetsrn Procédé d'inactivation virale des produits plasmatiques par des fluides supercritiques ou subcritiques.
FR2699408B1 (fr) 1992-12-21 1995-03-24 Bioland Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
US5723012A (en) 1993-12-09 1998-03-03 Bioland Uses for a current of supercritical carbon dioxide as an antiviral agent
US6652818B1 (en) * 1998-11-13 2003-11-25 Regeneration Technologies, Inc. Implant sterilization apparatus
US6613278B1 (en) * 1998-11-13 2003-09-02 Regeneration Technologies, Inc. Tissue pooling process
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US7081133B2 (en) 1999-01-19 2006-07-25 Carbomedics Inc. Antibiotic treated implantable medical devices
WO2002007785A2 (en) 2000-07-20 2002-01-31 Sulzer Carbomedics Inc. Implantable biocompatible animal tissue

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018526056A (ja) * 2016-01-08 2018-09-13 アクロ バイオメディカル カンパニー． エルティーディー．Ａｃｒｏ Ｂｉｏｍｅｄｉｃａｌ Ｃｏｍｐａｎｙ． Ｌｔｄ． 無細胞角膜、その製造方法、及びその使用

Also Published As

Publication number Publication date
US7008591B2 (en) 2006-03-07
WO2003033035A1 (en) 2003-04-24
CA2462717C (en) 2010-09-28
CA2462717A1 (en) 2003-04-24
EP1436016A1 (en) 2004-07-14
US20030072677A1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
US7008591B2 (en) Supercritical fluid extraction process for tissue preparation
AU770935B2 (en) Tissue pooling process
CA2817732C (en) Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
Duarte et al. Contributions of supercritical fluid technology for advancing decellularization and postprocessing of viable biological materials
KR101410533B1 (ko) 생체조직 유래 소재의 처리방법
JPH07505071A (ja) ウイルスの不活性化方法
AU2002364511A1 (en) Eb matrix production from animal tissue and its use for tissue repair
Zhou et al. Tendon allograft sterilized by peracetic acid/ethanol combined with gamma irradiation
CN112236175A (zh) 制备用于外科手术植入的生物组织的方法
EP3952936B1 (en) A process for prevention of degradation and degeneration of tissue used in bioprosthesis
US20130225669A1 (en) Sterilization of proteinaceous biomaterials and tissues with genipin
US20080038364A1 (en) Methods of processing body parts for surgery
EP0748632B1 (fr) Procédé de traitement antiviral des tissus biologiques à trame collagénique
RU2691983C1 (ru) Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида
US10004819B2 (en) Tissue allograft sterilization method
EP1210134A1 (fr) Procede de fabrication d'un materiau de prothese osseuse par traitement d'un tissu osseux naturel
Mukhopadhayay et al. Sterilization of biomaterials and medical devices with supercritical CO2
AU2019360728B2 (en) Mammal-derived matrix as a safe bone replacement
Yusof Interaction of radiation with tissues
HK40043705A (en) Method for preparing biological tissue for surgical implantation
Huie et al. NOVEL SUPERCRITICAL CARBON DIOXIDE STERILIZATION OF ABSORBABLE BIOMATERIALS
Wolfinbarger Jr et al. Principles of Tissue Decontamination and Sterilization

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090116

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090306

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090316

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090414

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091030